SCREEN-ERR^®

SCREEN-ERR^® is a service designed to help companies evaluate multiple pharmaceutical trademark candidates at an early stage in the trademark development process. It is used to determine whether any regulatory or other concerns exist which may result in a name not being acceptable to regulatory health authorities. SCREEN-ERR should be used as a tool to help eliminate unacceptable trademarks candidates from the list of proposed trademark candidates.

The SCREEN-ERR service is not intended to replace or supercede the Med-E.R.R.S. trademark safety testing process, the ERRS MODEL™, as SCREEN-ERR does not test for handwritten or verbal confusability of trademarks.

Under the SCREEN-ERR service, trademark candidates are reviewed for any issues related to non-proprietary names, regulatory issues at FDA and/or EMEA (primarily those that involve DDMAC [Division of Drug Marketing, Advertising and Communication] or equivalent groups within other health authorities); Internet-based search engines; other Internet-based resources for issues related to the name; and selected drug information resources.

SCREEN-ERR ideally should be used after preliminary legal screening has taken place.

A report will be generated that will contain an overview of the methods used for this screening process as well as tables containing the trademark candidates. Each trademark candidate will be given a rating reflecting its acceptability. For those with an unacceptable or questionable rating, the reason for this rating will be explained.

Click here for printable PDF version